Non-Hodgkin Lymphoma Journal Articles
- Safety of Sequential Biological Therapy in IBD
- Vedolizumab in Elderly and Nonelderly IBD Patients
- Plerixafor on a WHIM: Promise or Fantasy of a CXCR4 Inhibitor
- Dopamine Use and Its Consequences in the Intensive Care Unit
- Screening of Esophageal Varices in HCV+ Cirrhotic Patients
- Comorbidities and Co-Medications Among People With HIV
- Thiopurine Discontinuation at Anti-TNF Initiation in IBD
- Safety of IV Golimumab in RA, PsA, and AS
- Factors for Thyroid Complications After Radiation Therapy
- Third mRNA Vaccine in Preventing COVID-19 Hospitalization
- Safety and Efficacy of Tofacitinib for Ulcerative Colitis
- Conditions Linked to Severe COVID-19 in Cancer Survivors
- Malignancy Risk in Patients With Secukinumab-treated Psoriasis
- Diagnostic Workup, Etiology of Hypercalcemia of Malignancy
- Immune Checkpoint Inhibitor Treatment Toxicity Risk in RA
- Risk of Severe Clinical Events After DAA Therapy in HIV/HCV
- Radiological Case: Primary Breast Lymphoma
- How I Diagnose Primary Mediastinal Large B-Cell Lymphoma
- Benefit of 5ASA Use After Anti-TNF or Immunomodulator in IBD
- Inguinal Lymphocele After Angiomyomatous Hamartoma Resection